Company Profiles

Genzyme has pioneered the development and delivery of transformative therapies for patients affected by rare and debilitating diseases for over 30 years. We accomplish our goals through world-class research, collaboration with the global patient community, and with the compassion and commitment of our employees. With a focus on rare diseases and multiple sclerosis, we are dedicated to making a positive impact on the lives of the patients and families we serve. Genzyme's portfolio of transformative therapies, which are marketed in countries around the world, represent groundbreaking and life-saving advances in medicine. As a Sanofi company, Genzyme benefits from the reach and resources of one of the world's largest pharmaceutical companies, with a shared commitment to improving the lives of patients.
Genzyme, a Sanofi company
500 Kendall Street,
Cambridge, MA 02142
Contact person: Bo Piela
VP Media Relations
Abbvie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2015, AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit Follow @abbvie on Twitter.
Abbvie Inc.
1 N Waukegan Rd
North Chicago, Illinois 60064-1802
United States
Phone number: (847) 932-7900

Britannia Pharmaceuticals Limited is a UK based pharmaceutical company specializing in niche innovative products for chronic and serious medical conditions, and in particular, the treatment of patients with Parkinson's disease.
The need for apomorphine as a treatment option for Parkinson's disease has led to the development of APO-go and other associated brands around the globe, which are available in many countries through our Distribution or Licensing Partners.
For more information please visit or
Britannia Pharmaceuticals Ltd
Britannia Pharmaceuticals Ltd
100 Berkshire Place, Wharfedale Road, Winnersh, RG41 5RD
Tel: +4401189215900
Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For product labeling, press releases and additional information about the Company, please visit
Biogen Idec
14 Cambridge Center
Cambridge, MA 02142

Merck Serono, with ~15,000 employees and total revenues of €6.3B in 2013, is the biopharmaceutical business of Merck. With headquarters in Darmstadt, Germany, Merck Serono offers leading brands in 150 countries to help patients with cancer, multiple sclerosis, infertility, endocrine and metabolic disorders as well as cardiovascular diseases. In the United States and Canada, EMD Serono operates as a separately incorporated subsidiary of Merck Serono. Merck Serono discovers, develops, manufactures and markets prescription medicines of both chemical and biological origin in specialist indications. We have an enduring commitment to deliver novel therapies in our core focus areas of neurology, oncology, immuno-oncology and immunology. For more information, please visit
Merck Serono is a business of Merck.
Merck KGaA
Frankfurter Strasse 250
64293 Darmstadt
Hotline +49 (0) 6151 72-5000

Novartis provides innovative healthcare solutions that
address the evolving needs of patients and societies.
Headquartered in Basel, Switzerland, Novartis offers a
diversified portfolio to best meet these needs: innovative
medicines, eye care, cost-saving generic pharmaceuticals,
preventive vaccines and over-the-counter products. Novartis
is the only global company with leading positions in these
areas. For more information please visit
Novartis Pharma AG
CH4002 Basel, Switzerland

Zambon is a leading Italian family company that has operated for 108 years in the chemical and pharmaceutical industries. The company is well-established in 3 therapeutic areas: respiratory, pain and woman care. Zambon is carrying on the 132 million Euro investments plan for the years 2013 – 2017 in supporting research and development. The Group entered into a new important therapeutic area, the Central Nervous System (CNS), with Safinamide for the treatment of Parkinson's disease. The CNS is the main drivers of the development strategy of the company. Zambon, headquartered in Milan, is present in 73 countries and 21 operating subsidiaries
Zambon Logo
Zambon S.p.A.
Bresso (Milano), via Lillo del Duca 10 - 20091 Bresso (MI-Italy).
Direct: +39-0266524265
Fax: +39-0266524844
Daiichi Sankyo is a Global Pharmaceutical Company with Corporate Origins in Japan.
We provide innovative products and services in more than 50 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our 30,000 employees worldwide, we create innovative new medicines, as well as new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.
Daiichi Sankyo Europe GmbH
Zielstattstrasse 48
81379 Munich, Germany
Phone +49 89 78080
Fax +49 89 7808267

Leading the world of electroceuticals by developing therapies that directly, and non-invasively, target nerve signal imbalances and restore normal neurological function to help patients live life to its fullest, electroCore LLC is a U.S. based healthcare company developing non-invasive Vagus Nerve Stimulation (nVNS) therapies for the treatment of multiple conditions. The gammaCore® is the first of its kind, hand-held device that uses proprietary electrical signals to treat primary headache disorders.

150 Allen Road, Suite 201
Basking Ridge,
NJ 07920
Tel: +1 973 290 0097
Fax: +1 973 290 9171

5 Nachum Heth St., POB 2059
Tirat Carmel, 3912001, Israel
Tel: 972-4-8131313

Powered by over 100 patents and winner of numerous technology awards, INSIGHTEC is the global leader in MR-guided Focused Ultrasound (MRgFUS) neurosurgery and developer of the ExAblate Neuro platform. The first company to successfully steer and focus ultrasound through the cranium, the ExAblate Neuro is presently an Investigational Device undergoing FDA clinical evaluation in the US and has a CE mark for essential tremor, Parkinsonian tremor and neuropathic pain.

INSIGHTEC is actively pursuing research and development to expand the applications for its technology with a goal of becoming a non-invasive standard of care in medicine.

Medtronic International Trading Sàrl
Route du Molliau 31
CH - 1131 Tolochenaz
Tél.: +41 (0)21 802 70 00

Founded in 1949 by Earl E. Bakken and Palmer J. Hermundslie in MN, USA, Medtronic has grown to become the world's largest independent medical technology company. At Medtronic, we're changing the face of chronic disease. By working closely with physicians around the world, we create therapies to help patients do things they never thought possible. Our medical technologies help make it possible for millions of people to resume everyday activities, return to work, and live better, longer. Each year, Medtronic therapies help more than seven million people.

Our six major businesses, available in 120 countries worldvide, focus their efforts around a condition or therapy type: Cardiac Rhythm Disease Management, Spinal and Biologics, CardioVascular, Neuromodulation, Diabetes, and Surgical Technologies.

Company & Contact Information
Neuronix Ltd.
P.O.B. 16, Yoqnea'm 20692
Tel: +972-4-903-8600

The NeuroAD System from Neuronix is a non-invasive medical device for the treatment of Alzheimer's Disease. The system combines transcranial magnetic stimulation (TMS) directed at specific brain regions affected by the disease, concurrently with cognitive training targeted to the same regions.This unique approach helps patients achieve measurable, sustained cognitive improvement shown to last up to one year.The patented technology has been proven to be highly effective across several clinical trials, including trials conducted at Harvard Medical School and in Israel.CE-marked and the first medical device approved for the treatment of mild-to-moderate AD, the NeuroAD Systemis commercially available in the EU and parts of Asia, and randomized trials are ongoing in the U.S., Israel and Europe.

Teva Pharmaceuticals
11100 Nall Ave,
Overland Park, KS 66211
(800) 221-4026

Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs and innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in approximately 60 countries. Teva's Specialty Medicines businesses focus on CNS, respiratory, oncology, pain, and women's health therapeutic areas as well as biologics. Teva employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.

Postbus 4270
5004JG Tilburg, Nederland
Telephone +31 (0) 13 5231020
Fax +31 (0) 13 5231029

VIVISOL is one of the premier European groups working in the home care sector, specialised in respiratory care, (in particular diagnosis, care of OSAS, oxygen therapy, mechanical ventilation) and also provide services in the fields of woundcare and telemedicine.

VIVISOL constantly focusses on developing, evolving and refining our respiratory care solutions through evaluation, assessment and comparison of the different options available in the healthcare sector. We aim to provide patients with the best service possible.

Hence, VIVISOL focuses on "IMPROVING THE QUALITY OF LIFE" of chronic patients, whose therapy is delivered at home or in comfortable residential facilities.